Ningxia Zhongke Biotechnology Co., Ltd (SHA:600165)
China · Delayed Price · Currency is CNY 3.890
-0.070 (-1.77%)
Feb 27, 2026, 3:00 PM CST
SHA:600165 Revenue
Ningxia Zhongke Biotechnology had revenue of 111.76M CNY in the quarter ending September 30, 2025, with 57.34% growth. This brings the company's revenue in the last twelve months to 488.14M, up 61.85% year-over-year. In the year 2024, Ningxia Zhongke Biotechnology had annual revenue of 345.32M with 20.87% growth.
Revenue (ttm)
488.14M
Revenue Growth
+61.85%
P/S Ratio
12.88
Revenue / Employee
585.30K
Employees
834
Market Cap
6.29B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 345.32M | 59.63M | 20.87% |
| Dec 31, 2023 | 285.69M | -395.44M | -58.06% |
| Dec 31, 2022 | 681.13M | 432.42M | 173.86% |
| Dec 31, 2021 | 248.72M | 129.60M | 108.80% |
| Dec 31, 2020 | 119.11M | -146.64M | -55.18% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition